Bodisen Biotech Announces Completion of New Manufacturing Facility and Sees Record 2005 Earnings
Tuesday March 15, 9:20 am ET

NEW YORK--(BUSINESS WIRE)--March 15, 2005--Bodisen Biotech, Inc., (stock symbol: BBOI, website: /) announced today that it has completed the construction of its new 609,840 square foot manufacturing facility. The new facility will double the annual production of Bodisen's organic fertilizer from 100,000 metric tons to 200,000 metric tons.

Ms. Qiong Wang, CEO of Bodisen, commented, "Although we will report record earnings for year 2004, we were unable to completely satisfy overwhelming customer demand for Bodisen branded products because of our production capacity of 100,000 metric tons. We are very pleased that our new manufacturing facility will double last year's production output to 200,000 metric tons, which will enable us to meet growing customer demand for our products. We have also ordered an additional three sets of new production lines, which will further expand our production capabilities."

Ms. Wang continued with her comments on the market environment: "One of the major milestones in the Chinese agricultural industry in the last few decades took place in recent months, which is the Chinese government's initiation of pro-farmer policies that have given farmers both long term ownership rights as well as increased disposable income to spend on fertilizers. As a result, we are seeing a very favorable market environment for our products as farmers are able to put more financial resources to the enrichment of soil in their fields. As we continue to expand our products lines as well as marketing efforts, we foresee record 2005 sales and earnings."

About Bodisen Biotech, Inc.

Bodisen is a leader in the manufacturing and marketing of "green" organic fertilizers in China. The company is located in the heart of Shaanxi Province, the gateway to the vast western regions of China. Its broad selection of 60 products includes solid and liquid fertilizers, as well as pesticides and insecticides, which address a variety of grain and vegetable crops.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

Bodisen Biotech, Inc.
Investor Relations, 212-566-3503
info@bodisen.com

Source: Bodisen Biotech, Inc.